Omkar Speciality Chemicals Exits Insolvency, New Board Takes Charge

Omkar Speciality Chemicals Limited has successfully exited the Corporate Insolvency Resolution Process (CIRP) following the National Company Law Tribunal's (NCLT) approval of its resolution plan on July 31, 2025. Control has transitioned to a new Board of Directors, with a primary focus on reviving business operations.

Reader Takeaway: Company exits insolvency, but revenue remains zero while losses persist. New management must execute revival plan.

What just happened

The company has officially completed its CIRP. This transition means the company is no longer under insolvency proceedings and is under the control of a newly appointed Board of Directors. The resolution plan, submitted by Kshitij Polyline Limited, involves a total resolution amount of ₹26.65 crore, with ₹9.734 crore already infused by September 2025.

Why this matters

This marks a critical turning point for Omkar Speciality Chemicals. It signals the end of its insolvency period and the beginning of a revival phase. For shareholders, the key concern is the new management's ability to restart operations, generate revenue, and steer the company back to profitability.

The backstory

The company had been undergoing the CIRP, indicating a period of financial distress. The financial results for the quarters ended June 30, September 30, and December 31, 2025, show zero revenue from operations and continued losses, ranging from ₹0.3284 crore to ₹0.5179 crore per quarter, with basic EPS at negative ₹0.16 to ₹-0.25.

What changes now

With the NCLT approval and the new Board in place, the company is expected to implement its turnaround strategy. Key appointments include Mr. Dipak Kumar Shaw as CEO and Mr. Ruhini Kumar Chakraborty as Independent Director. Committees like the Audit Committee and Stakeholder’s Relationship Committee have also been reconstituted.

Risks to watch

The primary risk is the company's inability to ramp up operations effectively and return to profitability. The absence of revenue in the reported periods highlights the significant challenge ahead for the new management.

Peer comparison

(Information not available in the filing)

Context metrics (time-bound)

• Resolution Plan Approval Date: July 31, 2025
• Funds Infused by Sept 2025: ₹9.734 crore
• Total Resolution Amount: ₹26.65 crore
• Q3 FY26 Loss: ₹0.3284 crore

What to track next

Investors should closely monitor the company's progress in resuming commercial activities, its ability to secure new orders, and the financial performance under the new management in the upcoming quarters.